de Roos A, Doornbos J, Rebergen S, van Rugge P, Pattynama P, van der Wall E E
Department of Diagnostic Radiology, University Hospital Leiden, The Netherlands.
Eur J Radiol. 1992 Mar-Apr;14(2):97-103. doi: 10.1016/0720-048x(92)90221-t.
Recent advances in cardiovascular applications of magnetic resonance (MR) imaging and phosphorus-31 spectroscopy are reported. MR velocity mapping is a valuable adjunct to conventional imaging techniques, providing information on flow velocities as well as on absolute blood flow volume in the aorta and pulmonary arteries. Recently, ultrafast MR techniques have become available to evaluate myocardial perfusion with the aid of MR contrast agents as perfusion marker. Dynamic MR imaging is a powerful tool to assess cardiac function and ventricular mass. In particular, right ventricular function and mass can be evaluated with great accuracy, contributing to improved assessment of the significance of disease processes which may affect the right heart. The role of phosphorus-31 spectroscopy of the heart is expanding for the evaluation of ischemic myocardial disease and cardiomyopathies. The phosphocreatine to adenosine triphosphate ratio appears to be a marker of disease in patients with cardiac hypertrophy. In conclusion, MR imaging and phosphorus-31 spectroscopy is gaining widespread acceptance for evaluation of many cardiovascular disease processes.
本文报道了磁共振(MR)成像和磷-31光谱在心血管应用方面的最新进展。MR速度映射是传统成像技术的一项有价值的辅助手段,可提供主动脉和肺动脉中血流速度以及绝对血流量的信息。最近,借助MR造影剂作为灌注标记物,超快MR技术已可用于评估心肌灌注。动态MR成像是评估心脏功能和心室质量的有力工具。特别是,右心室功能和质量可得到非常准确的评估,有助于更好地评估可能影响右心的疾病过程的重要性。心脏磷-31光谱在评估缺血性心肌病和心肌病方面的作用正在扩大。磷酸肌酸与三磷酸腺苷的比率似乎是心脏肥大患者疾病的一个标记物。总之,MR成像和磷-31光谱在评估许多心血管疾病过程中越来越被广泛接受。